Proteinuria Treatment Market Forecast and Segments, 2016-2026
American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market.
American Diabetic Association stated that people with high blood pressure and diabetes are at high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients worldwide are the main driving factors for the growth of proteinuria treatment market.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Report Description<br />
In diabetes, the main causes of proteinuria are high blood glucose levels over a period of years.<br />
Pre-eclampsia, a condition which can affect pregnant women, includes very high blood pressure<br />
<strong>and</strong> is another potential cause of protein in the urine.<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-<br />
1486<br />
<strong>Proteinuria</strong> <strong>Treatment</strong> <strong>Market</strong>: Segmentation<br />
<strong>Proteinuria</strong> treatment market can be segmented on the basis of drug type, distribution channel<br />
<strong>and</strong> geography.<br />
Based on drug type, proteinuria treatment market can be segmented as follows:<br />
• ACE inhibitors (angiotensin-converting enzyme inhibitors)<br />
• ARBs (angiotensin receptor blockers)<br />
• DPP (dipeptidyl peptidase) IV inhibitors<br />
Based on distribution channel, proteinuria treatment market can be segmented as<br />
follows:<br />
• Hospitals including hospital pharmacies<br />
• Clinics<br />
• Retail Pharmacies
Change language